Longevity Health (XAGE) Competitors $2.43 +0.22 (+9.95%) As of 09:40 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock XAGE vs. LYRA, BTCY, INBS, TNON, LUCY, ICU, CODX, HSCS, SSKN, and POAIShould you be buying Longevity Health stock or one of its competitors? The main competitors of Longevity Health include Lyra Therapeutics (LYRA), Biotricity (BTCY), Intelligent Bio Solutions (INBS), Tenon Medical (TNON), Innovative Eyewear (LUCY), SeaStar Medical (ICU), Co-Diagnostics (CODX), HeartSciences (HSCS), Strata Skin Sciences (SSKN), and Predictive Oncology (POAI). These companies are all part of the "medical equipment" industry. Longevity Health vs. Its Competitors Lyra Therapeutics Biotricity Intelligent Bio Solutions Tenon Medical Innovative Eyewear SeaStar Medical Co-Diagnostics HeartSciences Strata Skin Sciences Predictive Oncology Lyra Therapeutics (NASDAQ:LYRA) and Longevity Health (NASDAQ:XAGE) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and media sentiment. Which has higher valuation and earnings, LYRA or XAGE? Longevity Health has lower revenue, but higher earnings than Lyra Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLyra Therapeutics$1.53M7.06-$93.43M-$60.50-0.11Longevity Health$560.67K3.96-$10.37MN/AN/A Is LYRA or XAGE more profitable? Longevity Health has a net margin of -1,535.11% compared to Lyra Therapeutics' net margin of -6,711.39%. Longevity Health's return on equity of 0.00% beat Lyra Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Lyra Therapeutics-6,711.39% -295.52% -66.95% Longevity Health -1,535.11%N/A -280.07% Which has more risk & volatility, LYRA or XAGE? Lyra Therapeutics has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500. Comparatively, Longevity Health has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Do insiders & institutionals believe in LYRA or XAGE? 95.6% of Lyra Therapeutics shares are held by institutional investors. Comparatively, 24.2% of Longevity Health shares are held by institutional investors. 3.3% of Lyra Therapeutics shares are held by company insiders. Comparatively, 29.0% of Longevity Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts recommend LYRA or XAGE? Lyra Therapeutics presently has a consensus target price of $100.00, indicating a potential upside of 1,381.48%. Given Lyra Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Lyra Therapeutics is more favorable than Longevity Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lyra Therapeutics 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Longevity Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor LYRA or XAGE? In the previous week, Lyra Therapeutics had 3 more articles in the media than Longevity Health. MarketBeat recorded 6 mentions for Lyra Therapeutics and 3 mentions for Longevity Health. Longevity Health's average media sentiment score of 0.94 beat Lyra Therapeutics' score of 0.88 indicating that Longevity Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lyra Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Longevity Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryLyra Therapeutics beats Longevity Health on 8 of the 14 factors compared between the two stocks. Get Longevity Health News Delivered to You Automatically Sign up to receive the latest news and ratings for XAGE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XAGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XAGE vs. The Competition Export to ExcelMetricLongevity HealthSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$2.62M$161.23M$2.54B$9.69BDividend YieldN/AN/A2.56%4.14%P/E RatioN/A2.3122.2125.31Price / Sales3.965.7879.07102.34Price / CashN/A3.9423.6858.50Price / Book-0.331.5236.446.01Net Income-$10.37M-$66.04M$31.01M$265.10M7 Day Performance-20.79%-5.02%0.51%1.39%1 Month Performance-17.54%-10.23%1.32%2.43%1 Year PerformanceN/A234.69%28.17%24.74% Longevity Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XAGELongevity HealthN/A$2.43+10.0%N/AN/A$2.44M$560.67K0.0014Gap UpLYRALyra Therapeutics3.6808 of 5 stars$6.70-2.8%$100.00+1,392.5%-55.4%$11.01M$1.53M-0.1150News CoverageEarnings ReportGap UpBTCYBiotricityN/A$0.44-6.1%N/A+16.3%$10.99M$12.06M-0.4140News CoverageUpcoming EarningsGap DownINBSIntelligent Bio Solutions0.9294 of 5 stars$1.52-1.9%N/A+25.6%$10.71M$3.11M0.0010TNONTenon Medical2.6399 of 5 stars$1.39+3.0%$4.67+235.7%+149.2%$10.25M$3.28M-0.058News CoverageLUCYInnovative Eyewear0.3347 of 5 stars$1.96-0.5%N/A-45.3%$9.01M$1.64M-0.499ICUSeaStar Medical0.9247 of 5 stars$0.78-1.7%N/A-90.0%$8.85M$140K-0.222CODXCo-Diagnostics4.2842 of 5 stars$0.25+3.1%$5.50+2,062.8%-77.9%$8.28M$3.91M-0.22100Upcoming EarningsGap UpHSCSHeartSciences2.5551 of 5 stars$3.59+1.4%$13.00+262.1%+7.6%$8.06MN/A-0.3810SSKNStrata Skin Sciences2.5619 of 5 stars$1.78-6.8%$6.00+237.1%-39.0%$7.97M$33.56M-0.78120News CoveragePOAIPredictive Oncology1.9925 of 5 stars$0.76+1.0%$3.00+294.8%-24.4%$7.69M$1.62M-0.2530 Related Companies and Tools Related Companies Lyra Therapeutics Alternatives Biotricity Alternatives Intelligent Bio Solutions Alternatives Tenon Medical Alternatives Innovative Eyewear Alternatives SeaStar Medical Alternatives Co-Diagnostics Alternatives HeartSciences Alternatives Strata Skin Sciences Alternatives Predictive Oncology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XAGE) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longevity Health Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longevity Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access